Scienture Holdings (SCNX) Current Leases (2019 - 2026)
Scienture Holdings' (SCNX) quarterly Current Leases came in at $2546.0 in Q2 2026, down 90.93% year-over-year from $28056.0 in Q2 2025, and down 74.55% quarter-over-quarter from $10004.0 in Q1 2026.
Analysis
Scienture Holdings (SCNX) Current Leases (2019 - 2026) Analysis & Trends
Scienture Holdings has disclosed Current Leases across 8 years of filings, most recently posting $2546.0 for Q2 2026.
- In Q2 2026, Current Leases fell 90.93% year-over-year to $2546.0; the TTM figure through Jun 2026 stood at $2546.0 (down 90.93% YoY), while the FY2025 annual figure was $24137.0, down 61.89% from the prior year.
- Current Leases came in at $2546.0 for Q2 2026 at Scienture Holdings, down from $10004.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $251087.0 in Q3 2023 to a low of $2546.0 in Q2 2026.
- Average Current Leases over 5 years is $99969.8, with a median of $63334.0 recorded in 2024.
- Year-over-year, Current Leases jumped 199.13% in 2022 and plunged 90.93% in 2026.
- Over 5 years, Current Leases stood at $196872.0 in 2022, then plunged by 83.44% to $32595.0 in 2023, then jumped by 94.31% to $63334.0 in 2024, then tumbled by 61.89% to $24137.0 in 2025, then plunged by 89.45% to $2546.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $2546.0 in Q2 2026, $10004.0 in Q1 2026, and $24137.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 9.04 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | - |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 11.82 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 8.80 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | 2,546.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,546.00 |
| Mar 31, 2026 | 10,004.00 |
| Dec 31, 2025 | 24,137.00 |
| Jun 30, 2025 | 28,056.00 |
| Mar 31, 2025 | 65,843.00 |
| Dec 31, 2024 | 63,334.00 |
| Jun 30, 2024 | 32,608.00 |
| Mar 31, 2024 | 32,608.00 |
| Dec 31, 2023 | 32,595.00 |
| Sep 30, 2023 | 251,087.00 |
| Jun 30, 2023 | 211,427.00 |
| Dec 31, 2022 | 196,872.00 |
| Sep 30, 2022 | 190,127.00 |
| Jun 30, 2022 | 183,066.00 |
| Mar 31, 2022 | 175,237.00 |
| Dec 31, 2021 | 178,561.00 |
| Sep 30, 2021 | 63,560.00 |
| Jun 30, 2021 | 90,628.00 |
| Mar 31, 2021 | 117,030.00 |
| Dec 31, 2020 | 131,153.00 |